DE602005010276D1 - Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält - Google Patents

Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält

Info

Publication number
DE602005010276D1
DE602005010276D1 DE602005010276T DE602005010276T DE602005010276D1 DE 602005010276 D1 DE602005010276 D1 DE 602005010276D1 DE 602005010276 T DE602005010276 T DE 602005010276T DE 602005010276 T DE602005010276 T DE 602005010276T DE 602005010276 D1 DE602005010276 D1 DE 602005010276D1
Authority
DE
Germany
Prior art keywords
peptide
pharmaceutical composition
composition containing
cell
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005010276T
Other languages
English (en)
Inventor
Patricia Rousselle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D ANJOU LAB
Centre National de la Recherche Scientifique CNRS
Original Assignee
D ANJOU LAB
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D ANJOU LAB, Centre National de la Recherche Scientifique CNRS filed Critical D ANJOU LAB
Publication of DE602005010276D1 publication Critical patent/DE602005010276D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE602005010276T 2004-07-29 2005-07-29 Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält Active DE602005010276D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408383A FR2873698B1 (fr) 2004-07-29 2004-07-29 Nouveau peptide et composition pharmaceutique le contenant
PCT/FR2005/001999 WO2006018551A1 (fr) 2004-07-29 2005-07-29 Nouveau peptide et composition pharmaceutique le contenant

Publications (1)

Publication Number Publication Date
DE602005010276D1 true DE602005010276D1 (de) 2008-11-20

Family

ID=34950308

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005010276T Active DE602005010276D1 (de) 2004-07-29 2005-07-29 Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält

Country Status (8)

Country Link
US (1) US7645740B2 (de)
EP (1) EP1784423B1 (de)
AT (1) ATE410448T1 (de)
CA (1) CA2575387C (de)
DE (1) DE602005010276D1 (de)
ES (1) ES2317308T3 (de)
FR (1) FR2873698B1 (de)
WO (1) WO2006018551A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2943062B1 (fr) 2009-03-13 2011-04-08 Symatese Nouveau peptide promoteur de l'adhesion et de la migration cellulaire
KR102065171B1 (ko) * 2019-02-20 2020-01-13 (주)케어젠 대기오염물질에 의한 피부 손상 방지 및 항노화용 펩타이드와 이의 용도
KR102474470B1 (ko) * 2020-11-25 2022-12-07 (주)케어젠 미세먼지에 의한 세포 손상 방지 활성을 갖는 펩타이드 및 이의 용도
KR102539445B1 (ko) * 2020-11-25 2023-06-05 (주)케어젠 미세먼지에 의한 세포 손상 방지 활성을 갖는 펩타이드 및 이의 용도
FR3127219A1 (fr) 2021-09-20 2023-03-24 Laboratoires D'anjou Nouveaux peptides et compositions pharmaceutiques et cosmetiques les contenants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294356B1 (en) * 1998-01-16 2001-09-25 Northwestern University Methods and materials for making and using laminin-5
AU4675300A (en) * 1999-04-30 2000-11-17 Biostatum, Inc. Recombinant laminin 5
JP4377522B2 (ja) * 2000-05-09 2009-12-02 株式会社ヤクルト本社 安定な酸性乳飲料、その製造方法およびこれに使用する酸性乳飲料用添加剤

Also Published As

Publication number Publication date
ATE410448T1 (de) 2008-10-15
ES2317308T3 (es) 2009-04-16
WO2006018551A1 (fr) 2006-02-23
EP1784423A1 (de) 2007-05-16
FR2873698A1 (fr) 2006-02-03
CA2575387C (fr) 2014-09-02
US7645740B2 (en) 2010-01-12
FR2873698B1 (fr) 2006-10-20
EP1784423B1 (de) 2008-10-08
WO2006018551A8 (fr) 2006-04-27
US20080064641A1 (en) 2008-03-13
CA2575387A1 (fr) 2006-02-23

Similar Documents

Publication Publication Date Title
BR0214029A (pt) Métodos e composições para o uso de células estromais para suportar células tronco embriÈnicas e adultas
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
NZ592911A (en) Leukolectins and uses thereof
UY27127A1 (es) Derivados de la urea como antagonistas de integrin alfa-4
NL300808I2 (nl) susoctocog alfa
HK1109070A1 (en) Treatment articles capable of conforming to an underlying shape
UY28258A1 (es) Tratamiento terapeutico
TR201903008T4 (tr) Kollajen-aracılı hastalıkları tedavi etmek için uygun bileşimler.
EE05212B1 (et) Polpeptiidi kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on m?eldud kasvajaraku raviks, mis ekspresseerib APRIL-i
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
RS54215B1 (en) COMPOSITIONS AND PROCEDURES FOR DIAGNOSIS AND TREATMENT OF CANCER
MXPA06003474A (es) Agonistas de receptores de melanocortina.
ATE410448T1 (de) Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält
DE602006012115D1 (de) Behandlung von amyotrophischer lateralsklerose mit pyrimethamin und analoga
DE60125563D1 (de) Verfahren zur verwendung eines humanen il-17 verwandten polypeptids zur behandlung von krankheiten
GB0620255D0 (en) Antibody and uses thereof
AR061352A1 (es) El uso de timosina alfa 1 para preparar un medicamento destinado al tratamiento del melanoma maligno de estadio iv
ATE526056T1 (de) Igf-2 peptid zur verwendung in einer tolerogenen behandlung für typ i diabetes
CY1108048T1 (el) Συνθεση σπογγοσινης
ECSP045210A (es) 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco
HUP0102046A2 (hu) CD137 alkalmazása perifériás monociták proliferációjának serkentésére
NO20052525D0 (no) Spleisevariant av humant hypofyseveksthormon
DE60132466D1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
DK1748785T3 (da) Peptider til modulering af bruskhomeostase
DE602004019141D1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition